Search

everythinglearnresearchcommunity

for

Search:↓

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Zinc sulphate solution was not effective in reducing the number, duration, or severity of recurrent herpes simplex infections.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

High-dose methotrexate can cause severe skin and nail issues.

The rash resolved after stopping ponatinib.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Skin ulcers from interferon may not depend on the amount given.

Diphencyprone therapy for hair loss can cause vitiligo.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Fetal exposure to diazoxide can cause hair loss and abnormal hair growth in infants.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Sulphadiazine can cause crystals to form in urine.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.